ZOETIS INC. (ZTS) Stock Price

ZTSStock

$77.29−50.73%52W

Market Cap$31.94B

P/E11.30x

PEG Ratio6.97

Div yield1.64%

Beta0.74

ZTS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-51.48%

Price vs S&P 500 (4W)-3.49%

PEG Ratio6.97

VGM Score50.35

P/E Ratio (Annual)11.30x

Indicated Dividend Yield (Annual)1.64%

P/CF (Annual)10.40x

Book Value / Share (Quarterly)$7.60

P/TBV (Annual)23.77x

Indicated Dividend (Annual)$2.12

Revenue Growth (3Y)5.42%

Cash Flow / Share (Quarterly)$5.71

Payout Ratio (TTM)33.98%

Price vs S&P 500 (YTD)-50.63%

Gross Margin (TTM)71.63%

Net Profit Margin (TTM)27.49%

EPS (TTM)$6.08

10-Day Avg Trading Volume5.20M

EPS Excl Extra (TTM)$6.08

Revenue Growth (5Y)7.24%

EPS (Annual)$6.02

Dividend / Share (Annual)$2.04

ROI (Annual)21.59%

Gross Margin (Annual)71.92%

Net Profit Margin (5Y Avg)26.98%

Cash / Share (Quarterly)$4.04

P/E Basic Excl Extra (TTM)11.54x

Revenue Growth QoQ (YoY)0.33%

EPS Growth (5Y)11.97%

P/E Normalized (Annual)11.30x

ROA (Last FY)17.28%

Revenue Growth TTM (YoY)1.41%

EBITD / Share (TTM)$7.89

ROE (5Y Avg)54.42%

Operating Margin (TTM)34.38%

Cash Flow / Share (Annual)$5.37

P/B Ratio9.59x

P/B Ratio (Quarterly)9.57x

Net Income / Employee (Annual)$184,300

EV / Revenue (TTM)3.97x

Net Interest Coverage (TTM)15.44x

ROA (TTM)17.19%

EPS Growth QoQ (YoY)2.64%

EV / EBITDA (TTM)11.12x

EPS Incl Extra (Annual)$6.02

Current Ratio (Annual)3.03x

Quick Ratio (Quarterly)1.83x

3-Month Avg Trading Volume7.01M

52-Week Price Return-50.73%

EV / Free Cash Flow (Annual)16.54x

P/E Incl Extra (TTM)11.54x

Revenue / Employee (TTM)$656,300

Tangible BV / Share (Quarterly)$5.38

P/S Ratio (Annual)3.19x

Asset Turnover (Annual)0.61x

52-Week High$158.30

Operating Margin (5Y Avg)33.71%

EPS Excl Extra (Annual)$6.02

CapEx CAGR (5Y)6.51%

Tangible BV CAGR (5Y)2.53%

26-Week Price Return-40.24%

Quick Ratio (Annual)1.94x

13-Week Price Return-3.62%

Total Debt / Equity (Annual)2.72x

Current Ratio (Quarterly)3.08x

Enterprise Value$37.77B

Revenue / Share Growth (5Y)8.87%

Asset Turnover (TTM)0.63x

Book Value / Share Growth (5Y)-0.24%

Revenue / Employee (Annual)$652,900

Inventory Turnover (Annual)1.12x

Pretax Margin (Annual)35.49%

Cash / Share (Annual)$5.44

3-Month Return Std Dev32.55%

Gross Margin (5Y Avg)70.68%

Net Income / Employee (TTM)$180,400

EBITDA CAGR (5Y)10.10%

EBITDA Interim CAGR (5Y)5.79%

ROE (Last FY)80.25%

Net Interest Coverage (Annual)12.66x

EPS Basic Excl Extra (Annual)$6.02

P/FCF (TTM)12.76x

Receivables Turnover (TTM)6.12x

EV / Free Cash Flow (TTM)15.96x

Total Debt / Equity (Quarterly)2.87x

EPS Incl Extra (TTM)$6.08

Receivables Turnover (Annual)6.52x

ROI (TTM)21.22%

Dividend Growth Rate (5Y)20.56%

P/S Ratio (TTM)3.17x

Pretax Margin (5Y Avg)33.71%

Revenue / Share (Annual)$21.33

Tangible BV / Share (Annual)$5.49

Forward P/E10.64x

Free OCF CAGR (5Y)6.41%

Price vs S&P 500 (52W)-69.04%

P/E Ratio (TTM)11.54x

EPS Growth TTM (YoY)4.59%

Year-to-Date Return-38.67%

5-Day Price Return4.34%

EPS Normalized (Annual)$6.02

ROA (5Y Avg)15.99%

Net Profit Margin (Annual)28.23%

Month-to-Date Return-0.16%

Cash Flow / Share (TTM)$5.96

EBITD / Share (Annual)$7.86

EPS Growth (3Y)10.25%

Operating Margin (Annual)35.49%

LT Debt / Equity (Annual)2.71x

P/CF (TTM)10.46x

ROI (5Y Avg)19.84%

P/E Excl Extra (TTM)11.54x

LT Debt / Equity (Quarterly)2.87x

EPS Basic Excl Extra (TTM)$6.08

P/TBV (Quarterly)13.51x

Payout Ratio (Annual)33.26%

P/B Ratio (Annual)16.65x

Dividend / Share (TTM)$2.07

Inventory Turnover (TTM)1.08x

Pretax Margin (TTM)34.38%

Book Value / Share (Annual)$7.84

Price vs S&P 500 (13W)-6.42%

Net Margin Growth (5Y)2.84%

Dividend Yield (TTM)2.94%

Beta0.74x

P/FCF (Annual)13.23x

Revenue / Share (TTM)$22.78

ROE (TTM)69.25%

52-Week Low$71.00

vGradeB

gGradeC

mGradeD

vgmGradeC

ZTS Earnings Surprise History

Q2 251.76est. 1.61

Q3 251.70est. 1.62

Q4 251.48est. 1.40

Q1 261.53est. 1.62

Q2 261.87est. 1.85

ZTS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.92

3.83

3.75

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
ZTSZOETIS INC.	B	C	D	$77.29
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About ZOETIS INC.

Zoetis is the global leader in animal health, offering vaccines, diagnostics, parasiticides, and anti-infectives for both companion and production animals. The company generates approximately 65% of revenue from companion animal products (dogs, cats, horses) and 35% from production animal health (cattle, pigs, poultry), with domestic operations tilted toward companion animals and international operations toward production animals. Spun from Pfizer's animal health unit, Zoetis holds the largest market share in the industry.